Search Results

Filter
  • 1-10 of  790,798 results for ""ANTINEOPLASTIC agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A chloromethyl-triazole fluorescent chemosensor for O 6 -methylguanine DNA methyltransferase.

  • Authors : Ayan S; Department of Chemical and Physical Sciences, University of Toronto Mississauga, Mississauga, Ontario, L5L 1C6, Canada. .; Rotaru AM

Subjects: Antineoplastic Agents*; Guanine/Guanine/Guanine/*analogs & derivatives; Temozolomide

  • Source: Organic & biomolecular chemistry [Org Biomol Chem] 2024 Apr 03; Vol. 22 (14), pp. 2749-2753. Date of Electronic Publication: 2024 Apr 03.Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101154995 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy ; Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/Small Cell Lung Carcinoma*/drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2023 Nov 30; Vol. 389 (22), pp. 2063-2075. Date of Electronic Publication: 2023 Oct 20.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells.

  • Authors : Zhu S; Brain Research Institute, Research Center of Neurological Diseases, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Rd, Shiyan, 442000, Hubei, China.; Guo J

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics

  • Source: Scientific reports [Sci Rep] 2023 Dec 09; Vol. 13 (1), pp. 21835. Date of Electronic Publication: 2023 Dec 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM.

  • Authors : Petronek MS; Department of Radiation Oncology, University of Iowa, Iowa City, Iowa.; Monga V

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/diagnostic imaging

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 17; Vol. 30 (2), pp. 283-293.Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265

Record details

×
Academic Journal

Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors.

  • Authors : Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .; Verschraegen CF

Subjects: Anemia*/Anemia*/Anemia*/chemically induced ; Anemia*/Anemia*/Anemia*/drug therapy ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects

  • Source: British journal of cancer [Br J Cancer] 2023 Aug; Vol. 129 (2), pp. 266-274. Date of Electronic Publication: 2023 May 12.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Study on the activation of cell death mechanisms: in search of new therapeutic targets in glioblastoma multiforme.

  • Authors : Gaiaschi L; Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Via Ferrata 9, 27100, Pavia, Italy. .; Favaron C

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

  • Source: Apoptosis : an international journal on programmed cell death [Apoptosis] 2023 Aug; Vol. 28 (7-8), pp. 1241-1257. Date of Electronic Publication: 2023 May 27.Publisher: Springer Country of Publication: Netherlands NLM ID: 9712129 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Discovery of new imidazotetrazinones with potential to overcome tumor resistance.

  • Authors : Summers HS; School of Chemistry, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.; Lewis W

Subjects: Antineoplastic Agents* ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2023 Sep 05; Vol. 257, pp. 115507. Date of Electronic Publication: 2023 May 21.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

From plant to cancer drug: lessons learned from the discovery of taxol.

Subjects: Antineoplastic Agents, Phytogenic*/Antineoplastic Agents, Phytogenic*/Antineoplastic Agents, Phytogenic*/pharmacology ; Antineoplastic Agents, Phytogenic*/Antineoplastic Agents, Phytogenic*/Antineoplastic Agents, Phytogenic*/chemistry ; Biological Products*/Biological Products*/Biological Products*/chemistry

  • Source: Natural product reports [Nat Prod Rep] 2023 Jul 19; Vol. 40 (7), pp. 1153-1157. Date of Electronic Publication: 2023 Jul 19.Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 8502408 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Adherence to oral hormonal anticancer agents in breast cancer.

  • Authors : Gori S; Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Verona, Italy.; Modena A

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Mouth Neoplasms*

  • Source: Tumori [Tumori] 2023 Jun; Vol. 109 (3), pp. 262-268. Date of Electronic Publication: 2022 May 21.Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach.

  • Authors : Ball P; School of Natural Sciences, Bangor University, Bangor, Gwynedd, Wales LL57 2UW, U.K.; Thompson E

Subjects: Prodrugs*/Prodrugs*/Prodrugs*/metabolism ; Prodrugs*/Prodrugs*/Prodrugs*/pharmacology ; Nitrogen Mustard Compounds*/Nitrogen Mustard Compounds*/Nitrogen Mustard Compounds*/metabolism

  • Source: Bioscience reports [Biosci Rep] 2023 Apr 26; Vol. 43 (4).Publisher: Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 8102797 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  790,798 results for ""ANTINEOPLASTIC agents""